New stem cell transplant for blood cancers without a matched donor
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a new way to perform a stem cell transplant for people with high-risk blood cancers who don't have a fully matched donor. It aims to offer a treatment option when a standard donor isn't available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a high-risk blood cancer that needs a stem cell transplant.
- You don't have a fully matched donor available.
- You haven't had a stem cell transplant in the last 3 months.
- You don't have an active serious infection, such as HIV or uncontrolled fungal infection.
- Your liver, heart, kidneys, and lungs are working well enough for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of stem cell transplant that removes certain immune cells (alpha-beta T cells and CD19 B cells) from the donor cells. This may help prevent graft-versus-host disease and other complications in patients with blood cancers who do not have a matched sibling donor.
This Phase 1 study tests a stem cell transplant plan that uses donor T-cells that have been specially processed and then added back. It aims to see if this approach is safer and works better for children and adults with serious blood cancers who need a transplant.
This trial tests a special stem cell transplant from a half-matched family donor, designed to reduce rejection and infection risk. It may include a targeted drug (blinatumomab) to help kill remaining cancer cells.
This study tests a special stem cell transplant for children and young adults with certain high-risk blood cancers or bone marrow diseases. It uses a half-matched family donor and a technique to remove specific cells, which may lower the risk of side effects and help the body accept the new cells.
This trial provides a special type of stem cell transplant for people under 22 years old who don't have a fully matched sibling donor. It uses a method to remove certain cells from the donor's stem cells to reduce the risk of graft-versus-host disease, where the donor cells attack the patient's body.
This trial uses a special type of stem cell transplant that removes certain cells to reduce complications. It may help people with blood diseases, immune problems, or other conditions that can be treated with a stem cell transplant.
Hear when a new Hematological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.